ClinicalTrials.gov · NCT07923630 · Not yet recruiting
Validation & Intervention Testing for Aging, Longevity and Healthspan
Registry record
NCT07923630 on ClinicalTrials.gov. The registry's last update to this record was 6 November 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Validation & Intervention Testing for Aging, Longevity and Healthspan Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor The University of Texas Health Science Center at San Antonio Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Dapagliflozin 10Mg Oral Tablet; Semaglutide oral; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Continuous Short Physical Performance Battery SPPB Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Not yet recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-11-06. Checked
Check history: NCT07923630 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: The University of Texas Health Science Center at San Antonio
- Phase: Phase 2
- Status: Not yet recruiting
- Intervention: Dapagliflozin 10Mg Oral Tablet; Semaglutide oral; Placebo
- Primary outcome: Continuous Short Physical Performance Battery SPPB
- Countries: United States
- Start: January 2027
- Completion (estimated): February 2031
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.